Johnson & Johnson ends talks to buy Actelion
The New Brunswick, New Jersey-based health care giant said Tuesday it was unable to reach a deal that would have created "adequate value" for its shareholders. Johnson & Johnson develops drugs and makes medical devices and other consumer products.
from Biotech News
0 Comments